Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Incyte
- Johnson & Johnson
Comparative performance (base 100)
Each asset is worth 100 at October 17, 2025; a value of 120 means +20% since that date (latest common date: October 16, 2026).
Indicators
"Not applicable" indicates a metric that has no meaning for this type of asset: it should not be compared.
| Indicator | IncyteStock | Johnson & JohnsonStock |
|---|---|---|
| Performance and risk | ||
| Performance over the periodChange in price between the first and last common dates. | +28.9% | +32.2% |
| Annualized performanceAverage annual return that would produce the same total performance. | +29.0% | +32.4% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 33.5% | 20.3% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −18.3% | −11.0% |
| Sharpe RatioReturn achieved above the risk-free rate (5.10%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | 0.94 | 1.49 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −2.8% | −2.1% |
| Fundamentals | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 22.83B $ | 610.38B $ |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 14.3 | 38.4 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 3.9 | 6.1 |
| Net marginShare of revenue retained as profit. | 27.7% | 16.2% |
| Return on equityReturn on equity (ROE). | 30.7% | Unavailable |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +37.7% | +5.9% |
| Dividend yieldAnnual dividend relative to the share price. | None | 2.12% |
| Debt / equityFinancial debt relative to shareholders' equity. | 1% | 58% |
Correlations over the period
From −1 to 1: close to 1, the two assets rise and fall together; close to 0, they move independently.
- Incyte / Johnson & Johnson0.31
Information provided for educational purposes only. It does not constitute investment advice or a personalized recommendation. Past performance is no guarantee of future results.